Kallikrein 5 antibody - Catalytic domain (ab40951)

Product Name 

Kallikrein 5 antibody - Catalytic domain

Product type 

Primary antibodies

Description 

Rabbit polyclonal to Kallikrein 5 - Catalytic domain

Immunogen 

Synthetic peptide based on the catalytic domain of human Kallikrein 5.(Peptide available as ab43087.)

Reacts with 
(species key)

Hu

Specificity 

This antibody is specific for Kallikrein 5, it does not react with the other Kallikreins (1-4, 6-15).

We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 5 antibodies

Tested applications 
(see key)

SDS-PAGE, WB

Abreviews 

Customer reviews (see key)

Read about Abreviews

Application notes 
(see key)

Recommended dilutions
SDS-PAGE: Use at an assay dependent dilution. Processed Kallikrein 5 has an apparent mass of 32-34 kDa on reduced SDS PAGE gels. WB: 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 32 kDa. Dilution optimised using Chromogenic detection. A range of different sized bands can be seen for Kallikrein 5 in different tissues and in cell culture media, ranging from 16-32 kDa and likely representing different proteolytically processed forms, but perhaps also the different splice variants. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Cellular localization 

Secreted

Research areas 

Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins
Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins

Relevance 

The human tissue Kallikrein gene family encodes 15 serine proteases. All Kallikreins share structural similarities including cysteine residues, a catalytic triad of His, Asp, and Ser residues, typically five coding exons, and varied intron phases. Kallikreins are predominantly secreted as inactive zymogens prior to activation by cleavage of an N terminal peptide, and all function extracellularly. Kallikreins can be activated autocatalytically, via other Kallikreins, or additional proteases. While structurally similar, Kallikrein family members have distinct functions and have key roles in many physiological and pathological processes. Many human tissue Kallikreins also show promise as cancer biomarkers, which may facilitate earlier detection and characterization of many forms of cancer.

Kallikrein 5 was originally described from the skin as an enzyme involved in turnover of the stratum corneum, and later cloned from human EST libraries as a Kallikrein like enzyme. The skin is known to contain trypsin like and chymotrypsin like proteinases of 32 kDa and 25 kDa respectively, and these were determined to be hK5 and hK7. Kallikrein 5 is found is greatest abundance in the skin, and also in the brain, with lesser signal in the kidney, lung, mammary gland, and testis. Human breast milk is reported to contain high levels of Kallikrein 5. Less stringent PCR detects hK5 in many tissues, and analysis of cell lines by Western blot shows that many cell lines make hK5.

Kallikrein 5 message is induced by estrogens in breast tumor cells, and hK5 has been reported to be elevated in ovarian cancer, but down regulated in prostate tumors, and kallikrein 5 has been reported to be elevated is sera of ovarian cancer patients Different splice variants of hK5 have also been implicated as markers in ovarian cancer. A 269 amino acid form with a shorter carboxyterminus that lacks the catalytic serine has been reported, as well as a 253 amino acid form using a different start site and containing a deletion that removes the catalytic cysteine. Endogenous inhibitors include kallistatin, protein C inhibitor and a1 proteinase inhibitor, although Kallikrein 5 can be found complexed to a number of different proteinase inhibitors. Pre-pro-kallikrein-5 has the 29 amino acid signal sequence that is removed before secretion, and the Pro-kallikrein-5 is activated to Kallikrein 5 by removal of the 37 amino acid propeptide domain. The full length hK5 sequence codes for a protein of 293 amino acids, with predicted mass of 32 kDa, and a very basic pI of 9.45, and the processed hK5 has an apparent mass of 32-34 kDa on reduced SDS PAGE gels. A range of different sized bands can be seen for Kallikrein 5 in different tissues and in cell culture media, ranging from 16-32 kDa, and likely representing different proteolytically processed forms, but perhaps also the different splice variants.

Database links 

Raised in 

Rabbit

Clonality 

Polyclonal

Isotype 

IgG

Purity 

Immunogen affinity purified

Storage buffer 

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Material safety datasheets (MSDS) for this product:
Glycerol MSDS
Sodium Azide MSDS

Form 

Liquid

Concentration 

1.000 mg/ml

Storage instructions 

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

See below for Kallikrein 5 antibody - Catalytic domain images, references, products related to ab40951 and other tools.

Kallikrein 5 antibody - Catalytic domain images:

Customer reviews (feedback) regarding Kallikrein 5 antibody - Catalytic domain

Customer FAQs regarding Kallikrein 5 antibody - Catalytic domain

Protocols for Kallikrein 5 antibody - Catalytic domain

Price and availability of products related to Kallikrein 5 antibody - Catalytic domain

Kallikrein 5 antibody - Catalytic domain - related products: